Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.
- DOI
- 10.1007/s41669-026-00656-9
- Published
- 2026 Jul
- Container
- PharmacoEconomics - open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s41669-026-00656-9,
title = {Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.},
author = {Wu YS and Burger EA and Holmboe F and Bangum M and Oteiza F and Bugge C and Sæther EM and Aas E},
year = {2026},
journal = {PharmacoEconomics - open},
doi = {10.1007/s41669-026-00656-9},
url = {https://doi.org/10.1007/s41669-026-00656-9}
}RIS
TY - JOUR TI - Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer. AU - Wu YS AU - Burger EA AU - Holmboe F AU - Bangum M AU - Oteiza F AU - Bugge C AU - Sæther EM AU - Aas E PY - 2026 JO - PharmacoEconomics - open DO - 10.1007/s41669-026-00656-9 UR - https://doi.org/10.1007/s41669-026-00656-9 ER -
APA
YS, W., EA, B., F, H., M, B., F, O., C, B., EM, S., & E, A. (2026). Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.. PharmacoEconomics - open. https://doi.org/10.1007/s41669-026-00656-9
Source records
- pubmed · retrieved 2026-09-26T16:43:06.988Z